SC
AKRO

Stempoint Capital’s Akero Therapeutics AKRO Stock Holding History

Stempoint Capital’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,500
Closed -$9.69K – 80
2025
Q3 		$9.69K Buy
+15,500
New +$751K ﹤0.01% 86

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Stempoint Capital's AKRO Position: Q4 2025 in Review

Stempoint Capital sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 121,410 shares — an estimated $5.76M sold.

Stempoint Capital first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $6.32M in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Stempoint Capital reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Stempoint Capital sold 121,410 Akero Therapeutics shares in Q4 2025, an estimated $5.76M.
  • Stempoint Capital first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
  • Stempoint Capital's Akero Therapeutics position peaked at $6.32M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.